
India must continue to fast-track its action to eliminate Rabies by 2030: ICMR-NIE
'Nearly 9.1 million animal bites and 5,726 human rabies deaths due to dog bites are estimated to occur every year in India.'
'80 per cent of the dog bite victims reported taking at least one dose of the vaccination. In order to eliminate dog-mediated rabies by 2030, India must continue to fast-track its action through a focused one health approach,' states a study done by ICMR-NIE.
The Ministry of Fisheries, Animal Husbandry and Dairy on the basis of release issued by the Ministry mentioned that States/UTs have reported, as per the data reported on the Integrated Disease Surveillance Programme (Integrated Health Information Platform) portal under the Ministry of Health and Family Welfare, that 2195122 dog bites cases in India during Jan-Dec'2024.
The primary objectives of the study are to estimate human rabies and deaths. 'The primary objectives of the study are to estimate the incidence of animal bites and to estimate human rabies deaths by decision tree model.'
'The secondary objectives are to estimate the proportion of animal bite cases receiving post-exposure prophylaxis, describe the anti-rabies vaccine supply chain at different levels of the health care system and estimate direct and indirect costs associated with animal bite cases,' states the study.
'During March 2022 to August 2023, we did a nationwide cross-sectional survey among individuals residing in 600 clusters across 60 districts in 15 Indian states. We employed a multistage cluster sampling design, utilising a probability sampling technique at every stage of selection. The head of the household or an adult family member was interviewed to collect information about the demographic details, bite history in any of the family members, type of biting animal, post bite animal status and circumstances leading to the animal bite, receipt of anti-rabies vaccination (ARV) and death after animal bite in the family. Annual animal bite incidence, along with 95% CI, was estimated after applying the sampling weights and adjusting for clustering.'
Study also revealed that the dog bite incidence was higher among children, below 14 years and elderly aged above 60 years, 'The dog bite incidence was higher among children aged 0-14 years (0.75 percent) and elderly aged above 60 years (0.78 percent) and among males (0.76 percent) and was not different in rural (0.58 percent) and urban (0.50 percent) areas (p=0.253). Among the dog bite victims, 79.5 percent (n=1,253) took at least one dose of anti-rabies vaccine. Using the decision tree/probability model we estimated 5,726 (95 percent CI: 3,967 - 7,350) human rabies deaths occurring every year in India.'
For a few years, Goa has maintained a rabies-free record. Sanchita Banerjee Rodrigues, Trustee - Panjim Animal Welfare Society, said, 'Goa has emerged as a model state in India for rabies control, having maintained its status as a rabies-controlled region for the last six years. This remarkable achievement is not by chance but by the sheer dedication and synergy of all stakeholders involved--government bodies, veterinarians, animal welfare volunteers, feeders, the Directorate of Animal Husbandry, DSPCA, and schools that play a key role in awareness and education.' 'Even when a rare case was reported last year in one of our islands in Goa involving a pet-owned dog, the response was swift and decisive. The entire village was sensitised, and containment protocols were immediately executed. This collective, community-driven action ensured that the situation was brought under control without panic or misinformation,' she said. On what other states/UTs can learn from Goa, she said, 'What other states can learn from Goa is the importance of cohesive teamwork. The key lies in consistent collaboration and trust among those on the ground and those in authority. Rabies control is not just about vaccines--it's about education, surveillance, early action, and deep-rooted community involvement. In Goa, feeders are the first responders, schools are awareness hubs, and volunteers serve as both watchdogs and caregivers. The veterinary community ensures scientific rigour, while the government ensures continuity of support, infrastructure, and accountability' 'The Goa model proves that rabies elimination is achievable in India with strategic planning and shared responsibility. It's not about isolated efforts, but a united front with a clear goal. As the country moves closer to the goal of 'Zero by 30', Goa stands as a shining example that with the right approach, the dream of a rabies-free India is within reach. It is time for other states to adapt, localise, and adopt Goa's spirit of collaboration and unwavering,' she said.
Dr. Rajesh Kumar, Associate Director - Internal Medicine, Paras Health, Gurugram said that the Rabies virus is the cause of the fatal viral disease rabies. It is primarily transmitted by the bite or scratch of an infected animal, usually a stray dog, but it can also be spread by bats, cats, and monkeys.
The virus causes inflammation in the brain by affecting the central nervous system.Once symptoms appear, such as fever, confusion, fear of water, and paralysis, it is almost always fatal.The risks linked to rabies are severe. If wounds from animal bites or scratches are not cleaned and treated correctly, they can lead to serious infections like sepsis, or localized bacterial infections, he said.
Doctor Kumar further said, Prevention is essential. Getting vaccinated on time is important for pets and for people at higher risk, like veterinarians, animal handlers. If someone gets bitten or scratched, they should wash the wound right away with soap and running water for at least 15 minutes. They should then seek medical evaluation and post-exposure prophylaxis (PEP), which includes anti-rabies vaccines and, if needed, rabies immunoglobulin. People should avoid contact with stray or wild animals and supervise children around animals. Keeping up with regular pet vaccinations and supporting community animal birth control and awareness programs are crucial in reducing the spread of rabies. (ANI)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Deccan Herald
2 hours ago
- Deccan Herald
India recorded over 7,000 suspected heatstroke cases
India reported 7,192 suspected heatstroke cases and only 14 confirmed deaths due to extreme heat between March 1 and June 24 this year, according to data obtained by PTI under the Right to Information (RTI) Act. The country had reported nearly 48,000 cases of heatstroke and 159 deaths due to extreme heat in 2024, the warmest year on record in India since 1901. The data, shared by the National Centre for Disease Control (NCDC), reveals that the majority of cases were reported in May, the peak of the summer season, with 2,962 suspected cases and three confirmed deaths. April saw 2,140 suspected cases and six confirmed deaths, while March recorded 705 cases and two deaths. During June, up to June 24, 1,385 suspected cases and three deaths were documented. Andhra Pradesh accounted for more than half of the total suspected heatstroke cases, reporting 4,055 during the period. Rajasthan reported 373 cases, followed by Odisha (350), Telangana (348) and Madhya Pradesh (297). Despite these high numbers, several states with hundreds of suspected cases reported no confirmed deaths. The data shows that Maharashtra and Uttarakhand reported the highest number of confirmed heatstroke deaths, at three each. Telangana, Odisha, Jharkhand, Tamil Nadu, Uttar Pradesh and West Bengal reported one death each. The figures highlight the limitations of India's surveillance system, which experts say captures only a fraction of the actual burden. The NCDC data is collected under the Integrated Disease Surveillance Programme (IDSP) and relies on hospitals to report cases. This means deaths that occur outside medical facilities or are not correctly diagnosed as heat-related often remain uncounted. A PTI investigation in June revealed that India's reporting of heat-related illnesses and deaths is fragmented, with different agencies presenting widely varying figures. For 2015-2022, the NCDC recorded 3,812 heat-related deaths, the National Crime Records Bureau (NCRB) reported 8,171, and the India Meteorological Department (IMD) reported 3,436.


Time of India
3 hours ago
- Time of India
Maker of GLP1 pens scales up for generic debuts
As weight-loss drug sales surge with semaglutide's patent expiration, Gujarat's Shaily Engineering Plastics, an injector pen manufacturer, anticipates significant growth. Its stock has nearly doubled, and the company is doubling its production capacity to 80-85 million pens by fiscal year-end to meet rising domestic and export demands. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Mumbai: With sales of weight-loss drugs surging and set to go up even more as semaglutide goes off patent early next year, a low-profile manufacturer of injector pens, Gujarat-based Shaily Engineering Plastics , is set to reap a windfall. Its stock has nearly doubled over the past 12 months. Manufacturers of the pen-like devices that make it easy to self-administer metered doses that would otherwise need to be injected with a syringe are the unnoticed beneficiaries of weight-loss drugs becoming is doubling capacity in line with plans of top pharma companies to launch generic versions of GLP1 weight-loss drugs early next year in India and overseas, said a senior company executive. It will be increasing capacity to 80-85 million pens by this fiscal year end from 40-45 million currently to cater to domestic and export demand, Sanjay Shah, chief strategy officer, told ET."We will look at further expansion and ramp up (in FY27). Currently, we are working with multiple players who are looking to launch generic semaglutide in different markets," he to Shah, various estimates suggest global demand for injector pens is likely to reach 500 million per year in the next two-three years and about 2 billion by is leading industry insiders to predict a looming supply crunch for pen leading drugmakers like Sun Pharma , Dr Reddy's, Cipla and Lupin are expected to be a part of the first-day launch wave in several international markets and India as soon as the patent is investing about '125 crore in FY26 on capacity expansion of its IP-led pen platform."We will be expanding (capacity) going forward to cater to the global as well as domestic market," said drugmaker Novo Nordisk 's weight-loss molecule semaglutide, branded Ozempic and Wegovy , will go off patent in March next year, opening up the gates for Indian and overseas drugmakers to launch cheaper generic expect an immediate price reduction of 50% and further by 60-80% over the coming years. This will boost affordability, potentially spurring sales of the drug and consequently, injector the past, shortages of both Eli Lilly's tirzepatide and Novo's semaglutide in the US were largely due to lack of devices and fill-n-finish capacities after demand for the drugs far outstripped supply.


The Hindu
3 hours ago
- The Hindu
The medical boundaries for AYUSH practitioners
The recent controversy on X between a hepatologist and an Indian chess Grand Master, on whether practitioners of traditional medicine can claim to be doctors, has sparked much commentary on the role and the status of practitioners of traditional Indian medicine systems such as Ayurveda and Unani, in India. Committees, governments, perspectives The burning issue here is not merely whether practitioners of Ayurveda can refer to themselves as doctors, but rather the scope of medical activities permitted under Indian law. This is an issue which has consequences for public health. A starting point for this discussion is to understand the framing of the debate over the last 80 years, beginning 1946, when the Health Survey and Development Committee, better known as Bhore Committee, batted in favour of modern scientific medicine based on evidence. The committee had pointed out that other countries were in the process of phasing out their traditional medicine systems and recommended that states take a call on the extent to which traditional medicine played a role in their public health systems. The Bhore committee's lack of enthusiasm for the traditional medicinal system did not go unnoticed by practitioners of traditional Indian medicine who mounted a vocal protest. They managed to convince the Government of India to set up the Committee on Indigenous Systems of Medicine, which submitted its report in 1948. This committee unabashedly wrapped up its conclusions in communal language, framing the issue in terms of Hindu nationalism by linking Ayurveda to the Vedas and its decline to 'foreign domination'. While the Nehru government took no action to formally recognise these practitioners of traditional medicine, the Indira Gandhi government in 1970 enacted a legislation called The Indian Medicine Central Council Act recognising and regulating the practitioners of Ayurveda, Siddha and Unani. This law was replaced in 2020 with a new law called The National Commission for Indian System of Medicine Act. The syllabus for aspiring practitioners of Ayurveda is an absolute mish-mash of concepts that span everything from doshas, prakriti, atmas (which includes learning the difference between paramatma and jivatma) with a sprinkling of modern medical concepts such as cell physiology and anatomy. These are irreconcilable concepts — the theory of tridosha attributes all ills to an imbalance of doshas, while modern medicine locates the concepts of some diseases such as infections in 'germ theory', among others. There is no middle ground between both systems of medicine which is why concepts such as integrative medicine make no sense. Point of friction Nevertheless, the legal recognition of this new class of practitioners led to questions on the exact boundaries between the practice of traditional and modern medicine. The major point of friction has been the prescription of modern medicines by the practitioners of traditional medicine. Ayurvedic practitioners, in particular, while claiming the superiority of their art over modern medicine, have consistently demanded the right to prescribe modern medicines developed by evidence-based modern science. Pertinently, this dispute revolved around the interpretation of Rule 2(ee) of the Drugs and Cosmetics Rules, 1945 which defined the class of 'registered medical practitioners' who can prescribe modern medicine. This definition is complicated since it is not limited to doctors with a MBBS degree. It delegates a certain amount of power to State governments to pass orders declaring medical practitioners on their State medical registers as persons 'practising the modern scientific system of medicine for the purposes of ….' the Drugs & Cosmetics Act, 1940. Many State governments have used this power under Rule 2(ee) to allow registered practitioners of Ayurveda and Unani to prescribe modern medicine such as antibiotics. The constitutionality of these orders was challenged before the courts and the first round of litigation concluded in 1998 with the judgment of the Supreme Court of India in Dr. Mukhtiar Chand & Ors vs The State Of Punjab & Ors. The Court concluded that 'the right to prescribe drugs of a system of medicine would be synonymous with the right to practise that system of medicine. In that sense, the right to prescribe allopathic drug cannot be wholly divorced from the claim to practice allopathic medicine'. Simply put, Ayurvedic practitioners had no right to prescribe modern medicine. That judgment never stopped the lobbying by Ayurvedic and Unani practitioners with State governments for the promulgation of orders under Rule 2(ee) allowing them to prescribe modern medicine. Several State governments have continued passing these orders in defiance of the Court's judgment. This inevitably leads to litigation before the High Courts, usually by the Indian Medical Association, which often wins these cases. Unsuspecting patients too have often sued practitioners of Ayurveda before consumer courts on the grounds that they were deceived into believing that they were being treated by a doctor with a MBBS degree who can prescribe modern medicine. While much of the litigation has revolved around the right to dispense modern medicine, there is also the issue regarding the medical procedures that can be conducted legally by practitioners of Ayurveda and Unani. For example, can a registered Ayurvedic practitioner 'intubate' a patient? This is an important question to ask since it is an open secret that many hospitals purporting to practise modern medicine are hiring Ayurvedic practitioners with Bachelor of Ayurvedic Medicine and Surgery (BAMS) degree at lower pay in place of graduates with a MBBS degree. Further, a notification by the Indian government in 2020 has allowed Ayurvedic practitioners (post graduates) to perform 58 minor surgeries, including the removal of the gall bladder, appendix and benign tumours. The constitutionality of this notification is pending before the courts. If the notification is upheld, the question that arises is whether these Ayurvedic practitioners can now use anaesthetic agents and antibiotics required to conduct surgeries. The stakes are high for public health in India since the likely strategy of Ayurvedic practitioners will be to argue that these surgeries were known in traditional Indian medicine. In these times of heady Hindutva, it will be difficult to find a judge who will ignore these claims. The political factor The larger political backdrop to this entire debate regarding Ayurvedic practitioners is 'Hindu pride', which has fuelled claims of fantastical achievements by ancient Indian civilisation, be it the pushpaka vimana or the claims of the Kauravas being test tube babies. When a policy issue such as Ayurveda is cynically draped in the language of 'Hindu pride', it is not just the Bharatiya Janata Party but also the Indian National Congress which feels compelled to support an obviously dangerous approach to public health. The last election manifesto of the Indian National Congress, in 2024, promised that the party would 'support' all systems of medicines instead of a promise to support only rational, evidence-based medicine. This blind faith in traditional medicine is going to cost every citizen in the future since the government is actively considering the inclusion of AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy) treatments under the Ayushman Bharat insurance scheme funded by tax-payers. This is in addition to approximately ₹20,000 crore of tax-payer money spent on research councils functioning under the Ministry of AYUSH with a mandate to research AYUSH. They have very little to show for in terms of scientific breakthroughs. Twitter outrage notwithstanding, the joke at the end of the day is on the tax-payer. Dinesh S. Thakur is the author of 'The Truth Pill: The Myth of Drug Regulation in India'. Prashant Reddy T. is the coauthor of 'The Truth Pill: The Myth of Drug Regulation in India'